William Grossman
Interim Chief Medical Officer at enGene Therapeutics · 1 reported transaction in 1 company · latest trade Sep 22, 2026
Their record
No purchases old enough to measure yet.
Their trades
Bought | Sep 22, 2026 | Sep 22, 2026 close $2.05 → Oct 27, 2026 close $1.55. S&P 500 −0.5% over the same days. |
BoughtenGene Therapeutics
$10.1K
Sep 22, 2026 close $2.05 → Oct 27, 2026 close $1.55. S&P 500 −0.5% over the same days.